(+)-Syringaresinol-di-O-β-d-glucoside, a phenolic compound from Acanthopanax senticosus Harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein-1 and/or nuclear factor-κB activities

Toxicology in Vitro

Volumn 21, Issue 8, 2007, Pages 1530-1537

  Yamazaki, T ^a   Shimosaka, S ^b   Sasaki, H ^b   Matsumura, T ^b   Tukiyama, T ^a   Tokiwa, T ^a  

^a Kohno Clinical Medicine Research Institute   (Japan)

^b Roman Industries Co Ltd   (Japan)

Author keywords

Acanthopanax senticosus; Inflammatory mediators; Matrix metalloproteinase; Phenolic compounds; Synovial sarcoma cells

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; ISOFRAXIDIN; PHENOL DERIVATIVE; PROSTAGLANDIN E2; SYRINGARESINOL; SYRINGARESINOL DI O BETA DEXTRO GLUCOSIDE; SYRINGIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG INHIBITION; DRUG ISOLATION; ELEUTHEROCOCCUS SENTICOSUS; HUMAN; HUMAN CELL; SYNOVIAL SARCOMA;

ACANTHOPANAX; CELL LINE, TUMOR; COUMARINS; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION; GLUCOSIDES; HUMANS; INTERLEUKIN-1BETA; LIGNANS; NF-KAPPA B; PHENYLPROPIONATES; RNA, MESSENGER; SARCOMA; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR AP-1;

ELEUTHEROCOCCUS SENTICOSUS;

EID: 36048959587     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.04.016     Document Type: Article

References (20)

1. Bondeson J., Brennan F.M., Foxwell B.M.J., and Feldmann M. Effective adenoviral transfer of IκBα into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines in nuclear factor κB dependent. Journal of Rheumatology 27 (2000) 2978-2989
2. Brekhmani I., and Dardymov I.V. New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology 19 (1969) 119-130
3. Chomczynski P., and Sacchi N. Single step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 (1987) 156-159
4. Crofford L.J., Wilder R.L., and Ristimak A.P. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin 1b, phobor ester, and corticosteroids. Journal of Clinical Investigation 93 (1994) 1095-1101
5. Deneule M., Brossard M., Page M., Gingras D., and Beliveau R. Matix metalloproteinase inhibition by green tea catechins. Biochimica et Biophysica Acta 1478 (2000) 51-60
6. Deyama T., Nishibe S., and Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacologica Sinica 22 (2001) 1057-1070
7. Elinos-Baez C.M., Leon F., and Santos E. Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro. Cell biology International 29 (2005) 703-708
8. Fujikawa T., Yamaguchi A., Morita I., Takeda H., and Nishibe S. Protective effects of Acanthopanax senticosus Harms from Hokkaido and its components on gastric ulcer in restrained cold water stressed rats. Biological and Pharmaceutical Bulletin 19 (1996) 1227-1230
9. Geng Y., Blanco F.J., Cornelisson M., and Lotz M. Regulation of cyclooxygenase 2 expression in normal human aricular chondrocytes. Journal of Immunology 155 (1995) 796-801
10. Lin N., Sato T., and Ito A. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metallproteinases 1 and 13 and augments those of tissue inhibitors of matrix metalloproteinase 1 and 2 in human synovial fibroblasts. Arthrithis and Rheumatism 44 (2001) 2193-2200
11. Mengshol J.A., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinsases as therapeutic targets in arthritic diseases. Bull's-eye or missing the mark?. Arthritis and Rheumatism 46 (2002) 13-20
12. Mix K.M., Mengshol J.A., Benbow U., Vincenti M.P., Sporn M.B., and Brinckerhoff C.E. A synthetic triterpenoid selectively inhibits the induction of matrix metallproteinases 1 and 13 by inflammatory cytokines. Arthrithis and Rheumatism 44 (2001) 1096-1104
13. Nishibe S., Kinoshita H., Takeda H., and Okano G. Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. Chemical and Pharmaceutical Bulletin 38 (1990) 1763-1765
14. Ren, C.-C., 1982. Gokahi. Zusetu Kampo-iyaku Daijiten (1). Tokyo: Kodansha, pp. 316-319 (In Chinese and Japanese).
15. Tokiwa T., Harada K., Matsumura T., and Tukiyama T. Oriental medicinal herb, Periploca sepium, extract inhibits growth and IL-6 production of human synovial fibroblast-like cells. Biological and Pharmaceutical Bulletin 27 (2004) 1601-1603
16. Tokiwa T., Yamazaki T., and Sakurai S. Anti-inflammatory effect of eleutheroside E from Acanthopanax senticosus. Food and Food Ingredients Journal of Japan 211 (2006) 576-582 (In Japanese with English abstract)
17. Vincenti M.P., Coon C.I., White L.A., Barchowsky A., and Brinckerhoff C.E. SRS-related tyrosine kinases regulate transcriptional activation of the intestitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts. Arthrithis and Rheumatism 39 (1996) 574-582
18. Yamazaki T., Yokoyama T., Akatsu H., Tsukiyama T., and Tokiwa T. Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone. In Vitro Cellular and Developmental Biology 39 (2003) 337-339
19. Yamazaki T., Shimosaka S., Sakurai M., Matsumura T., Tsukiyama T., and Tokiwa T. Anti-inflammatory effects of a major component of Acanthopanax senticosus Harms, isoflaxidin. Journal of Electrophoresis 48 (2004) 55-58 (In Japanese with English abstract)
20. Yamazaki T., Tsukiyama T., and Tokiwa T. The effect of dexamethasone on transcriptional factors, NF-κB and AP-1, binding activity in a human synovial sarcoma cell line, SW982. In Vitro Cellular and Developmental Biology 41 (2005) 80-82